Literature DB >> 11773322

Relaxation by vasoactive intestinal polypeptide in the gastric fundus of nitric oxide synthase-deficient mice.

Joëlle M C Dick1, Wim Van Molle, Peter Brouckaert, Romain A Lefebvre.   

Abstract

In many gastrointestinal tissues nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) both play a role as inhibitory non-adrenergic non-cholinergic neurotransmitters. As the mode of interaction between NO and VIP remains controversial, the aim of this study was to investigate the interplay between NO and VIP in the mouse gastric fundus and to evaluate the nitric oxide synthase (NOS) isoform involved in VIP-induced relaxation by using inducible NOS (iNOS), endothelial NOS (eNOS) and neuronal NOS (nNOS) knockout mice. The influence of NOS inhibitors on the relaxant effect of VIP was determined in isolated smooth muscle cells and smooth muscle strips of wild-type and knockout mice. In isolated smooth muscle cells from wild-type, eNOS knockout and nNOS knockout mice, the relaxation induced by VIP (10(-9) M) was inhibited by approximately 70-95 % by both the non-selective NOS inhibitor N(G)-nitro-L-arginine (L-NA; 10(-4) M) and the selective inducible NOS inhibitor N-(3-(aminomethyl)-benzyl)acetamidine (1400W; 10(-6) M). In cells isolated from iNOS knockout mice, VIP still induced full relaxation but it was not influenced by L-NA or 1400W. In smooth muscle strips from wild-type and knockout mice, the concentration-dependent relaxation by VIP (10(-9) to 3 x 10(-7) M) was not influenced by L-NA or 1400W. These results suggest that the experimental method determines the influence of NOS inhibitors on the relaxant effect of VIP. iNOS, probably induced by the isolation procedure, might be involved in the relaxant effect of VIP in isolated smooth muscle cells but not in classic smooth muscle strips.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773322      PMCID: PMC2290014          DOI: 10.1113/jphysiol.2001.012906

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Human tyrosine hydroxylase isoforms. Inhibition by excess tetrahydropterin and unusual behavior of isoform 3 after camp-dependent protein kinase phosphorylation.

Authors:  J Alterio; P Ravassard; J Haavik; J P Le Caer; N F Biguet; G Waksman; J Mallet
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

3.  Evidence for dual components in the non-adrenergic non-cholinergic relaxation in the rat gastric fundus: role of endogenous nitric oxide and vasoactive intestinal polypeptide.

Authors:  M D'Amato; D Currò; P Montuschi
Journal:  J Auton Nerv Syst       Date:  1992-03

4.  Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning.

Authors:  J Imagawa; D M Yellon; G F Baxter
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Parallel pathways mediate inhibitory effects of vasoactive intestinal polypeptide and nitric oxide in canine fundus.

Authors:  O Bayguinov; K D Keef; B Hagen; K M Sanders
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

6.  Role of nitric oxide and vasoactive intestinal polypeptide in vagally mediated relaxation of the gastric corpus in the anaesthetized ferret.

Authors:  D Grundy; M K Gharib-Naseri; D Hutson
Journal:  J Auton Nerv Syst       Date:  1993-06

7.  Involvement of the L-arginine: nitric oxide pathway in nonadrenergic noncholinergic relaxation of the cat gastric fundus.

Authors:  A J Barbier; R A Lefebvre
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

8.  Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells.

Authors:  B Teng; K S Murthy; J F Kuemmerle; J R Grider; K Sase; T Michel; G M Makhlouf
Journal:  Am J Physiol       Date:  1998-08

9.  Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells.

Authors:  J G Jin; K S Murthy; J R Grider; G M Makhlouf
Journal:  Am J Physiol       Date:  1993-03

10.  Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis.

Authors:  J R Grider
Journal:  Am J Physiol       Date:  1993-02
View more
  6 in total

1.  A minor role for Ca2+ sensitization in sustained contraction through activation of muscarinic receptor in circular muscle of rat distal colon.

Authors:  Tadayoshi Takeuchi; Hidemitsu Nakajima; Fumiaki Hata; Yasu-Taka Azuma
Journal:  Pflugers Arch       Date:  2007-02-23       Impact factor: 3.657

2.  Gastric motility in soluble guanylate cyclase alpha 1 knock-out mice.

Authors:  Gwen Vanneste; Ingeborg Dhaese; Patrick Sips; Emmanuel Buys; Peter Brouckaert; Romain A Lefebvre
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

3.  Long-term dietary L-arginine supplementation increases endothelial nitric oxide synthase and vasoactive intestinal peptide immunoexpression in rat small intestine.

Authors:  Ksenija Velickovic; Milica Markelic; Igor Golic; Vesna Otasevic; Ana Stancic; Aleksandra Jankovic; Milica Vucetic; Biljana Buzadzic; Bato Korac; Aleksandra Korac
Journal:  Eur J Nutr       Date:  2013-10-08       Impact factor: 5.614

4.  Localised calcium release events in cells from the muscle of guinea-pig gastric fundus.

Authors:  S P Parsons; T B Bolton
Journal:  J Physiol       Date:  2003-11-07       Impact factor: 5.182

5.  Role of the superior salivatory nucleus in parasympathetic control of choroidal blood flow and in maintenance of retinal health.

Authors:  Chunyan Li; Malinda E C Fitzgerald; Nobel Del Mar; Hongbing Wang; Corey Haughey; Marcia G Honig; Anton Reiner
Journal:  Exp Eye Res       Date:  2021-03-16       Impact factor: 3.467

6.  NANC inhibitory neurotransmission in mouse isolated stomach: involvement of nitric oxide, ATP and vasoactive intestinal polypeptide.

Authors:  Flavia Mulè; Rosa Serio
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.